Eletriptan Hydrobromide and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Eletriptan Hydrobromide and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eletriptan
Brand name: Relpax
Synonyms: Eletriptan
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eletriptan Hydrobromide-Insulin degludec
- Eletriptan Hydrobromide-Insulin Degludec (U-100) Prefilled Pens
- Eletriptan Hydrobromide-Insulin Degludec (U-100) Vials
- Eletriptan Hydrobromide-Insulin Degludec (U-200) Prefilled Pens
- Eletriptan Hydrobromide-Insulin degludec and liraglutide
- Eletriptan Hydrobromide-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Elexacaftor, Tezacaftor and Ivacaftor
- Insulin aspart, recombinant Subcutaneous-Elfolate
- Insulin aspart, recombinant Subcutaneous-Elidel
- Insulin aspart, recombinant Subcutaneous-Elidel Topical
- Insulin aspart, recombinant Subcutaneous-Eligard
- Insulin aspart, recombinant Subcutaneous-Eliglustat